Biomarkers are a big deal in the clinical world: if as a doctor you’re able to take one simple measurement that allows you to look into a patient’s future, you’ve potentially elevated your practice of medicine from imprecise art to exact science. The better the biomarkers in your arsenal, the more information you have to…

“Aging” isn’t a disease as recognized by the FDA–not yet anyway. But then how will the companies trialing anti-aging drugs ever get regulatory approval? It’s simple: just choose a “primary indication” to test your drug with. Of course, that choice itself is rather difficult when you’re considering a geroprotector. Here’s how investors think about it…

The year is 1996, and you’re a doctor with a strange case on your hands. Actually, it’s not just one case–it’s an entire family with a collection of rare disorders and unrelated bodily dysfunction. Must be something genetic, right? But it doesn’t look like any of the genetic diseases you’ve seen before, because it’s going…

Last week we heard the theoretical side of Dr. Michael Fossel’s mission to bring aging to its knees, and why his chosen point of attack was on the grand orchestrator of the body’s repair processes. This week he goes into the practical details: how does he plan to lengthen telomeres? What can we treat with…

With three decades of experience as a professor of clinical medicine under his belt, Dr. Michael Fossel takes a fundamentally pragmatic approach to tackling human aging. It’s with this attitude that he has championed telomerase therapy, in the process writing multiple well-received books on the biology of aging and its clinical implications, as well as…

Laboratories studying the biology of aging are a menagerie of creatures great and small. From unicellular yeast and nematodes, all the way up to primates and even the faithful old Canis familiaris, animal models have opened up the aging process to our inspection in ways that human subjects wouldn’t have been able to match. It’s…

Researchers from Houston Methodist Research Institute took cells from patients with progeria, a devastating condition that causes premature aging, and turned back the clock by lengthening their telomeres. Besides helping to cure a fatal disease, could these anti-aging benefits transfer to non-pathological aging? turned back the clock Men and women age differently–that’s no secret. But…

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD